News

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine — the nation's only traditional ...
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...
In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine ...
Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
A Department of Health and Human Services spokesperson called the move "a radical departure from past practices." ...
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
Vaccinations for Covid-19 are now underway in the U.S. Two vaccines – one from Pfizer and BioNTech, one from Moderna — have ...